Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma.
Opinion Statement: The incidence of metastatic pheochromocytoma (PHEO) and paraganglioma (PGL) may occur in as many as 35% of patients particularly with PGL and even more frequently in those with specific mutations. Biochemical, morphological, and molecular markers have been investigated for use in...
| Publicado en: | Current Treatment Options in Oncology Vol. 21; no. 11; pp. 1 - 19 |
|---|---|
| Autores principales: | , , , |
| Formato: | review Journal Article |
| Publicado: |
Springer Nature
Nov2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |